证券代码：605009 证券简称：豪悦护理 公告编号：2024-039 杭州豪悦护理用品股份有限公司 关于以集中竞价交易方式回购公司股份方案的回购报告书 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承法律责任。 重要内容提示： ●审议程序：杭州豪悦护理用品股份有限公司（以下简称"公司"或"上市公司"） 的《关于以集中竞价交易方式回购公司股份方案的议案》经公司于 2024 年 8 月 26 日召开的第三届董事会第九次会议审议通过，并经公司于2024年9月9日召开的2024 年第二次临时股东大会审议通过。 ●拟回购股份的用途：用于注销减少公司注册资本及股权激励计划。 ●拟回购股份的资金总额：回购资金总额不低于人民币 5,000 万元（含），不超 过人民币 10,000 万元（含）。 ●拟回购股份的价格：不超过人民币 40.00 元/股（含 40.00 元/股，该回购价格 上限不高于董事会通过回购决议前 30 个交易日公司股票交易均价的 150%）。 1、若本次回购期限内，公司股票价格持续超出回购方案披露的价格区间，则存 在本次回购方案无法实施 ...

杭州豪悦护理用品股份有限公司（以下简称"公司"或"上市公司"）于 2024 年 9 月 9 日召开 2024 年第二次临时股东大会，审议通过《关于以集中竞价交易 方式回购公司股份方案的议案》，同意本次实际回购股份数量之 50%将用于注销 减少公司注册资本；实际回购股份数量之 50%将用于股权激励计划，若公司未能 在本次回购完成之后 36 个月内实施股权激励计划，则公司回购的股份将依法予 以注销。 具体内容详见公司披露于上海证券交易所网站《杭州豪悦护理用品股份公司 关于以集中竞价交易方式回购股份方案的公告》（公告编号：2024-034）。 杭州豪悦护理用品股份有限公司 关于回购注销部分股票通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605009 证券简称：豪悦护理 公告编号：2024-040 特此公告 杭州豪悦护理用品股份有限公司董事会 上述回购的股份部分将用于注销，将导致公司注册资本减少，根据《中华人 民共和国公司法》等相关法律、法规的规定，公司债权人自接到公司通知起 30 日内、未接到通知者自 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 杭州豪悦护理用品股份有限公司（以下简称豪悦护理或公司）于 2024 年 8 月 26 日召开第三届董事会第九次会议，审议通过了《关于以集中竞价交易方式 回购公司股份方案的议案》，具体内容详见公司 2024 年 8 月 27 日披露在上海证 券交易所网站（www.sse.com.cn）的《杭州豪悦护理用品股份有限公司关于以集 中竞价交易方式回购股份方案的公告》（公告编号：2024-034）。 根据《上市公司股份回购规则》等相关规定，现将公司 2024 年第二次临时 股东大会股权登记日（2024 年 9 月 3 日）登记在册的前十大股东和前十大无限 售条件股东的名称及持股数量、比例情况公告如下： 证券代码：605009 证券简称：豪悦护理 公告编号：2024-038 杭州豪悦护理用品股份有限公司 关于回购股份事项前十大股东和前十大无限售条件 股东持股情况的公告 一、2024 年 9 月 3 日登记在册的前十大股东持股情况 杭州豪悦护理用品股份有限公司董事会 10 香港上海汇丰银行有限 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2024-036 杭州豪悦护理用品股份有限公司 关于股东提前终止减持计划 暨一股未减的减持结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上述减持主体存在一致行动人： 1 一、集中竞价减持主体减持前基本情况 股东名称 股东身份 持股数量 （股） 持股 比例 当前持股股份来源 杭州希望众创实业投资 合伙企业（有限合伙） 5%以下股 东 6,247,272 4.02% IPO 前取得：4,192,800 股 其他方式取得：2,054,472 股 股东持股的基本情况 杭州希望众创实业投资合伙企业（有限合伙）（以下简称"希望众创"） 系杭州豪悦护理用品股份有限公司（以下简称"公司"）股东,与控股股 东(控股股东包含李志彪、朱威莉、李诗源)为一致行动人，现持有公司 首次公开发行股票并上市前股份 4,192,800 股，上市后以资本公积金 转增股份方式取得 2,054,472 股,合计持有 6,247,272 股，占公司总股 本的比例为 4.02%。 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2024-035 杭州豪悦护理用品股份有限公司 关于 2024 年第二次临时股东大会增加临时提案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东大会有关情况 (一) 现场会议召开的日期、时间和地点 | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | Ａ股 | 605009 | 豪悦护理 | 2024/9/3 | 二、 增加临时提案的情况说明 公司已于 2024 年 8 月 24 日公告了股东大会召开通知，单独或者合计持有 34.65%股份的股东李志彪，在 2024 年 8 月 26 日提出临时提案并书面提交股东 大会召集人。股东大会召集人按照《上市公司股东大会规则》有关规定，现予以 公告。 1. 股东大会的类型和届次： 2024 年第二次临时股东大会 2. 股东大会召开日期：2024 年 9 月 9 日 3. 股权登记日 1. 提案人：李志彪 2. 提案程序说明 3. 临时提案的具体内容 李 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2024-034 杭州豪悦护理用品股份公司 关于以集中竞价交易方式回购股份方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 拟回购股份的用途：用于注销减少公司注册资本及股权激励计划。 拟回购股份的资金总额：回购资金总额不低于人民币 5,000 万元（含），不 超过人民币 10,000 万元（含）。 拟回购股份的价格：不超过人民币 40.00 元/股（含 40.00 元/股，该回购价 格上限不高于董事会通过回购决议前 30 个交易日公司股票交易均价的 150%）。 回购期限：自公司股东大会审议通过回购股份方案之日起不超过 6 个月（窗 口期顺延）。 回购资金来源：公司自有资金。 相关股东是否存在减持计划：根据公司于 2024 年 5 月 22 日披露的《杭州豪 悦护理用品股份有限公司关于股东集中竞价减持股份计划的公告》，公司股东杭 州希望众创实业投资合伙企业(有限合伙)披露了减持股份计划，计划通过集中竞 价方式减持不超过 150 万股，减持期间 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2024-033 杭州豪悦护理用品股份有限公司 第三届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 二、董事会会议审议情况 杭州豪悦护理用品股份有限公司（以下简称"公司"）第三届董事会第九次 会议于 2024 年 8 月 26 日（星期一）在公司会议室以现场结合通讯的方式召开， 会议通知已于 2024 年 8 月 26 日通过短信及邮件的方式送达全体董事。经全体董 事同意，豁免本次会议通知时限要求。本次会议由董事长李志彪先生主持，会议 应出席董事 7 人，实际出席董事 7 人。公司监事、高级管理人员列席本次会议。 本次会议的召集、召开符合《公司法》《公司章程》的有关规定，决议内容合法 有效。 具体详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《杭州 豪悦护理用品股份有限公司关于以集中竞价交易方式回购股份方案的公告》 （二）回购股份的用途：用于注销减少公司注册资本及股权激励。 （三）回购股份的方式：通 ...

Section I Definitions [Definitions of Common Terms](index=5&type=section&id=常用词语释义) This section defines common terms used in the report, including company names, controlling shareholders, and the reporting period, to ensure accurate interpretation - "Haoyue Shares", "Company", "Joint Stock Company", "the Company" all refer to Hangzhou Haoyue Nursing Products Co., Ltd[8](index=8&type=chunk) - Controlling shareholders and actual controllers are Li Zhibiao, Zhu Weili, Li Shiyuan[8](index=8&type=chunk) - Reporting period is from January 1, 2024, to June 30, 2024[8](index=8&type=chunk) Section II Company Profile and Key Financial Indicators [Company Basic Information](index=5&type=section&id=公司基本信息) This section outlines the company's basic registration information, contact details, information disclosure channels, and stock overview, clarifying its legal name and securities information - Company's Chinese name is Hangzhou Haoyue Nursing Products Co., Ltd., abbreviated as Haoyue Nursing[9](index=9&type=chunk) - Company's legal representative is Li Zhibiao[9](index=9&type=chunk) - Company's shares are listed on the Shanghai Stock Exchange, stock code **605009**[13](index=13&type=chunk) - Company's designated information disclosure newspapers are "Shanghai Securities News" and "Securities Times", and the website is http://www.sse.com.cn[12](index=12&type=chunk) [Company's Key Accounting Data and Financial Indicators](index=7&type=section&id=公司主要会计数据和财务指标) During the reporting period, the company's operating revenue and net profit attributable to shareholders slightly decreased year-on-year, while net profit excluding non-recurring gains and losses increased, with significant changes in cash flow and asset structure Key Accounting Data (Jan-Jun 2024 vs. Prior Year) | Indicator | Current Period (Jan-Jun) | Prior Year Period | Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 1,313,081,079.32 yuan | 1,357,068,724.04 yuan | -3.24 | | Net Profit Attributable to Listed Company Shareholders | 194,022,001.88 yuan | 199,731,105.89 yuan | -2.86 | | Net Profit Attributable to Listed Company Shareholders After Deducting Non-recurring Gains and Losses | 191,598,579.81 yuan | 188,714,602.23 yuan | 1.53 | | Net Cash Flow from Operating Activities | 115,002,587.69 yuan | 314,629,579.86 yuan | -63.45 | | **Period-end Indicators** | **Current Period-end** | **Prior Year-end** | **Change (%)** | | Net Assets Attributable to Listed Company Shareholders | 3,281,852,138.60 yuan | 3,217,398,470.92 yuan | 2.00 | | Total Assets | 4,503,507,010.88 yuan | 4,646,744,348.48 yuan | -3.08 | Key Financial Indicators (Jan-Jun 2024 vs. Prior Year) | Indicator | Current Period (Jan-Jun) | Prior Year Period | Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (yuan/share) | 1.24 | 1.28 | -3.13 | | Diluted Earnings Per Share (yuan/share) | 1.24 | 1.28 | -3.13 | | Basic Earnings Per Share After Deducting Non-recurring Gains and Losses (yuan/share) | 1.23 | 1.21 | 1.65 | | Weighted Average Return on Equity (%) | 5.88 | 6.45 | -0.57 | | Weighted Average Return on Equity After Deducting Non-recurring Gains and Losses (%) | 5.81 | 6.09 | -0.28 | [Non-recurring Gains and Losses Items and Amounts](index=7&type=section&id=非经常性损益项目和金额) Total non-recurring gains and losses for the current period amounted to 2.42 million yuan, primarily from government subsidies and investment income, impacting the company's net profit Non-recurring Gains and Losses Items and Amounts (Unit: Yuan) | Non-recurring Gains and Losses Item | Amount | | :--- | :--- | | Disposal gains/losses of non-current assets | -176,232.39 | | Government subsidies recognized in current profit/loss | 2,571,440.18 | | Gains/losses from entrusted investments or asset management | 1,891,862.50 | | Reversal of impairment provisions for receivables subject to separate impairment testing | 220,000.00 | | Other non-operating income and expenses | -1,657,616.85 | | Less: Income tax impact | -426,031.37 | | Total | 2,423,422.07 | Section III Management Discussion and Analysis [Explanation of the Company's Industry and Main Business Operations During the Reporting Period](index=9&type=section&id=报告期内公司所属行业及主营业务情况说明) This section details the market size, consumption trends, channel changes, and competitive landscape of the absorbent hygiene products industry, along with the company's main business product composition and revenue contribution - Market size of absorbent hygiene products in China reached **116.04 billion yuan in 2023**, a **4.1% year-on-year increase**[22](index=22&type=chunk) - Female hygiene products market size **70.34 billion yuan**, **up 8.2%**; infant hygiene products market size **32.26 billion yuan**, **down 6.2%**; adult incontinence products market size **13.46 billion yuan**, **up 11.3%**[22](index=22&type=chunk) - Company's main business covers R&D, manufacturing, and sales of feminine, infant, and adult hygiene care products, including baby diapers, adult diapers, period pants, sanitary napkins, and wet wipes[30](index=30&type=chunk) Main Business Revenue Composition (2024 Reporting Period) | Product Category | Revenue (Million Yuan) | Proportion of Operating Revenue (%) | | :--- | :--- | :--- | | Infant hygiene products | 898 | 68.40 | | Adult hygiene products | 263 | - | | Other products | 152 | - | | Total | 1,313 | 100 | [Industry Overview During the Reporting Period](index=9&type=section&id=报告期内公司所属行业情况) The absorbent hygiene products industry is undergoing continuous market structure adjustments driven by evolving consumer demands, emerging channels, the rise of domestic brands, and demographic shifts, with pant-style sanitary napkins and adult incontinence products emerging as key growth areas - Changes in consumer demand drive market growth, with scientific and refined parenting concepts leading to higher quality requirements for infant products[23](index=23&type=chunk) - Emerging channels like maternal and child stores, e-commerce platforms, live streaming, short videos, and O2O platforms make consumption more convenient, with a clear trend of online-offline integration[24](index=24&type=chunk) - "Made in China" quality is reshaping the brand landscape, with domestic diaper manufacturers rapidly gaining market share through R&D and high-quality products[25](index=25&type=chunk) - Pant-style sanitary napkins have become a significant new growth area in the female hygiene products market due to excellent leak protection and absorption, with a substantial increase in consumption[26](index=26&type=chunk) - Infant diaper market size decreased by **6.2%**, but penetration rate rose to **84.5%**, with pant-style products accounting for **45.9%**, and demand for larger size diapers continuously growing[27](index=27&type=chunk) - Aging population trend drives growth in the adult incontinence products market, with market size increasing by **11.1%** and consumption by **14.1% in 2023**[28](index=28&type=chunk) [Explanation of the Company's Main Business Operations During the Reporting Period](index=13&type=section&id=报告期内公司主营业务情况说明) The company's main business involves the R&D, manufacturing, and sales of feminine, infant, and adult hygiene care products, with infant hygiene products accounting for 68.40% of revenue, showcasing various independent brands and their product series - Company's main products include infant hygiene products, adult hygiene products, and other hygiene products[30](index=30&type=chunk) - Infant hygiene products revenue **898 million yuan**, accounting for **68.40% of the company's operating revenue**[30](index=30&type=chunk) - Independent brand Hope baby launched China-made ultra-thin series, luxurious red camellia series, and seaweed luxurious moisturizing series of tape-style/pant-style diapers[32](index=32&type=chunk) - FOREST SAYS brand launched Forest Story Oxygen Bubble feminine period pants, day/night sanitary napkins, panty liners, plant extract intimate wet wipes, and cream moisturizing tissues[34](index=34&type=chunk) - Dafi brand focuses on pure water flushable wet wipes, kitchen wet wipes, cloud-soft facial towels, pure water wet wipes, down jacket cleaning wet wipes, and shoe cleaning wet wipes[35](index=35&type=chunk)[36](index=36&type=chunk) - mamamia brand launched Cloud Mulberry Robe Growth Series baby diapers, emphasizing age-specific customization and intelligent parenting solutions[37](index=37&type=chunk) - Overseas subsidiary HAOYUE(THAILAND)CO.,LTD launched Sunny Baby LUXURY, FREELY, FLEXI, PREMIUM MAX series baby diapers/pull-ups and baby cleaning wet wipes[38](index=38&type=chunk) - Adult hygiene product Comfrey brand launched classic series and traditional Chinese medicine skin-friendly series of adult tape-style/pant-style diapers, diaper pads, and nursing pads[40](index=40&type=chunk) - Pet product Sunny Doggy brand launched regular, thickened, printed, and deodorizing versions of pet training pads[41](index=41&type=chunk) [Analysis of Core Competencies During the Reporting Period](index=21&type=section&id=报告期内核心竞争力分析) The company's core competitiveness is built upon continuous product innovation, a high-standard quality management system, scaled production, diversified premium customer resources, and lean production management, collectively supporting its market position and sustainable development - Company continuously invests in R&D, launching innovative products like easy-to-wear period pants and baby pull-ups through market research and new material application, and obtaining invention patents[42](index=42&type=chunk) - Established a strict quality management system, implementing I Quality refined management covering product design, raw material procurement, manufacturing, sales, and after-sales service[43](index=43&type=chunk) - Company has production bases in Hangzhou, Jiangsu, Thailand, Hubei, and will add a Hefei factory, possessing scaled production advantages with capacity ranking among the top in China[44](index=44&type=chunk) - Accumulated high-quality customer resources including globally renowned multinational companies like Unicharm and Kao, and well-known domestic maternal and child brands like BabyCare and Kidswant[46](index=46&type=chunk) - Promotes lean production site management, combining "Amoeba" and digitalization to achieve "single order accounting", enhancing production-sales coordination and operational efficiency[47](index=47&type=chunk) [Discussion and Analysis of Operations](index=23&type=section&id=经营情况的讨论与分析) During the reporting period, the company focused on online channel promotion, product optimization, major client collaboration, and overseas market expansion, enhancing operational efficiency and competitiveness through factory acquisition, digital management, and lean production - Company continuously increased investment in online channel promotion, fostered the development of independent brands, optimized product structure, and iterated new products[48](index=48&type=chunk) - Accumulated **186 patents** during the reporting period, including **15 invention patents**, **147 utility model patents**, and **24 design patents**[49](index=49&type=chunk) - Independent brand Forest Story feminine hygiene product stores launched on major platforms, introducing day-use easy-change period pants, and collaborating with celebrity influencers for promotion[49](index=49&type=chunk) - Thailand market developed steadily, with own brand Sunny Baby adjusting products based on local market research and expanding online and offline sales channels[50](index=50&type=chunk) - Hubei Haoyue factory successfully passed major client product verification, preparing for large-scale order production[50](index=50&type=chunk) - Acquired Hefei Kao factory assets and completed the handover, undertaking technical transformation to expand production scale and form new profit growth points[50](index=50&type=chunk) - Implemented MES system, integrating SAP, WMS, AGV scheduling, OA, digital twin, and other systems to achieve full-process production management and data analysis, enhancing intelligence[50](index=50&type=chunk) - Fully implemented lean production management, configuring online inspection equipment such as vision systems and metal detection systems, to improve product quality and production efficiency[50](index=50&type=chunk) - Enhanced team management capabilities by integrating resources, optimizing business processes, and strengthening training for key personnel[51](index=51&type=chunk) [Key Operating Conditions During the Reporting Period](index=26&type=section&id=报告期内主要经营情况) During the reporting period, the company experienced decreased revenue and costs, significantly increased sales expenses, and reduced net operating cash flow, with shifts in asset-liability structure primarily due to large-denomination certificate of deposit purchases and fixed asset investments Analysis of Changes in Financial Statement Items (Jan-Jun 2024 vs. Prior Year) | Item | Current Period Amount (Yuan) | Prior Year Period Amount (Yuan) | Change (%) | Explanation of Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 1,313,081,079.32 | 1,357,068,724.04 | -3.24 | Raw material prices decreased, leading to lower selling prices | | Operating Cost | 931,766,547.02 | 1,007,742,256.82 | -7.54 | Company's production costs decreased | | Sales Expenses | 94,341,731.50 | 59,471,985.85 | 58.63 | Company increased promotion of its own brands | | Net Cash Flow from Operating Activities | 115,002,587.69 | 314,629,579.86 | -63.45 | Decrease in short-term borrowings, accounts payable, and notes payable | | Net Cash Flow from Investing Activities | -737,281,599.26 | -102,140,363.05 | -621.83 | Increase in fixed asset investments and purchase of large-denomination certificates of deposit | | Net Cash Flow from Financing Activities | -157,905,271.81 | 95,017,429.54 | -266.19 | Repayment of borrowings in the current period | Changes in Assets and Liabilities (Period-end vs. Prior Year-end) | Item Name | Current Period-end Amount (Yuan) | Change (%) | Explanation | | :--- | :--- | :--- | :--- | | Monetary Funds | 1,513,023,542.66 | -34.10 | Primarily due to purchase of regular large-denomination certificates of deposit | | Accounts Receivable | 149,497,546.77 | 114.73 | Primarily due to decrease in customer prepayments | | Construction in Progress | 324,654,176.59 | 62.32 | Primarily due to new equipment purchased by the company not yet reaching intended usable state | | Other Non-current Assets | 379,500,000.00 | 279.50 | Primarily due to increase in large-denomination certificates of deposit in the current period | | Other Payables | 25,422,068.24 | -30.87 | Primarily due to dividend payments in the current period | - Overseas assets amounted to **183,535,929.18 yuan**, accounting for **4.08% of total assets**[53](index=53&type=chunk) - Restricted assets at period-end included monetary funds of **161,141.26 yuan**, restricted as acceptance bill deposits[53](index=53&type=chunk) Analysis of Major Holding and Invested Companies (2024 Reporting Period) | Company Name | Business Nature | Shareholding (%) | Total Assets (Yuan) | Net Assets (Yuan) | Net Profit (Yuan) | | :--- | :--- | :--- | :--- | :--- | :--- | | Jiangsu Haoyue Industrial Co., Ltd. | Manufacturing | 100% | 425,795,650.98 | 356,980,413.72 | 26,921,635.65 | [Potential Risks](index=30&type=section&id=可能面对的风险) The company faces multiple risks including macroeconomic volatility, intensified market competition, raw material price fluctuations, and declining birth rates, which it addresses through continuous product innovation, R&D, cost control, market expansion, and seizing opportunities in adult and period pant markets - Macroeconomic risk: The market size of disposable hygiene products is affected by macroeconomic factors such as national economic development, residents' disposable income, birth rates, and the degree of population aging; continuous decline in birth rates may impact the company's performance[56](index=56&type=chunk) - Market competition risk: Industry competition is intensifying, shifting from price competition to brand and quality competition, with domestic and international brands competing on product quality and price; the company needs to effectively formulate and implement R&D, production, brand, and marketing development plans[57](index=57&type=chunk)[58](index=58&type=chunk) - Raw material price fluctuation risk: Major raw materials are petroleum derivatives, subject to significant price fluctuations due to international situations, which may adversely affect the company's net profit and profit margins. The company has mastered core material production technology to strengthen cost control[59](index=59&type=chunk) - Risk of declining birth rates: China's newborn population decreased by **540,000 in 2023** year-on-year, which may affect the growth of the domestic infant hygiene products market. The company will consolidate its advantages, strengthen independent brand building, and expand into the adult diaper and period pant markets[60](index=60&type=chunk) Section IV Corporate Governance [Brief Introduction to General Meetings of Shareholders](index=32&type=section&id=股东大会情况简介) During the reporting period, the company held its 2024 first extraordinary general meeting and 2023 annual general meeting, approving key proposals including business scope changes, articles of association amendments, and profit distribution - On January 15, 2024, the company held its 2024 first extraordinary general meeting, reviewing and approving the "Proposal on Changing the Company's Business Scope, Company Domicile, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration"[61](index=61&type=chunk)[62](index=62&type=chunk) - On May 6, 2024, the company held its 2023 annual general meeting, reviewing and approving 11 proposals including the "2023 Board of Directors Work Report" and "2023 Profit Distribution Plan"[61](index=61&type=chunk)[62](index=62&type=chunk) [Profit Distribution or Capital Reserve Conversion Plan](index=33&type=section&id=利润分配或资本公积金转增预案) The board approved the 2024 semi-annual profit distribution plan to pay a cash dividend of 8.5 yuan per 10 shares (tax inclusive) to all shareholders, totaling 131.52 million yuan, a plan also approved by the supervisory board - The company's 2024 semi-annual profit distribution plan is: a cash dividend of **8.5 yuan (including tax)** for every **10 shares** to all shareholders[3](index=3&type=chunk)[63](index=63&type=chunk) - Total distributed profit is **131,515,890.45 yuan**, with a total share capital of **154,724,577 shares** participating in the distribution[3](index=3&type=chunk) - The supervisory board believes the plan complies with the company's articles of association and cash dividend policy, the decision-making process is legal and compliant, and it is conducive to the company's healthy development[63](index=63&type=chunk) Section V Environmental and Social Responsibility [Environmental and Social Responsibility](index=33&type=section&id=第五节%20环境与社会责任) This section did not disclose environmental information for the company as a key pollutant-discharging entity, nor did it mention subsequent environmental disclosure progress, carbon reduction measures, or specific details on poverty alleviation and rural revitalization efforts Section VI Significant Matters [Fulfillment of Commitments](index=35&type=section&id=承诺事项履行情况) The company's controlling shareholders, actual controllers, directors, supervisors, senior management, and other shareholders strictly fulfilled all IPO-related commitments during the reporting period, including share lock-up, resolving horizontal competition, and ensuring prospectus truthfulness - Company's controlling shareholders, actual controllers Li Zhibiao, Zhu Weili, and Li Shiyuan, as well as all company directors, supervisors, and senior management, timely and strictly fulfilled all commitments[67](index=67&type=chunk)[68](index=68&type=chunk) - Commitments include share reduction price not lower than the issue price, automatic extension of lock-up period, restrictions on share transfers during director/senior management tenure, standardization of related-party transactions, non-occupation of company funds, responsibility for social insurance and housing provident fund supplementary payment, assumption of leasing risks, etc[70](index=70&type=chunk)[71](index=71&type=chunk)[72](index=72&type=chunk)[73](index=73&type=chunk)[74](index=74&type=chunk)[75](index=75&type=chunk)[76](index=76&type=chunk)[77](index=77&type=chunk)[78](index=78&type=chunk) - Company shareholders Xiwang Zhongchuang and Wenzhou Outai also fulfilled commitments such as share lock-up and resolution of horizontal competition[68](index=68&type=chunk)[70](index=70&type=chunk)[77](index=77&type=chunk)[78](index=78&type=chunk) [Major Contracts and Their Fulfillment](index=44&type=section&id=重大合同及其履行情况) This section primarily discloses the company's leasing activities as a lessee, listing multiple contracts with related and non-related parties, with lease terms spanning from 2019 to 2026 - Company, as lessee, signed leasing contracts with multiple companies, with lease terms extending from **2019 to 2026**[82](index=82&type=chunk) - Leasing contracts involve Hangzhou Shenying Hardware Manufacturing Co., Ltd., Hangzhou Dawang Plastic Co., Ltd., Hangzhou Jiamei International Packaging Co., Ltd., Hangzhou Kejia Commercial Management Co., Ltd., Hangzhou Dingsheng Light Alloy Material Co., Ltd., Hangzhou Jiali Refrigeration Machine Co., Ltd., and overseas subsidiary Haoyue (Thailand) Co., Ltd. with Bangna Service[82](index=82&type=chunk) Section VII Share Changes and Shareholder Information [Share Capital Changes](index=47&type=section&id=股本变动情况) During the reporting period, the company's total share capital and share structure remained unchanged - During the reporting period, there were no changes in the company's total share capital or share structure[84](index=84&type=chunk) [Shareholder Information](index=47&type=section&id=股东情况) As of the end of the reporting period, the company had 15,858 common shareholders, with Li Zhibiao, Zhu Weili, and Li Shiyuan, the actual controllers, collectively holding 66.44% of the shares directly and indirectly among the top ten - As of the end of the reporting period, the total number of common shareholders was **15,858**[84](index=84&type=chunk) Top Ten Shareholders' Shareholding as of the End of the Reporting Period | Shareholder Name | Number of Shares Held | Shareholding (%) | Shareholder Nature | | :--- | :--- | :--- | :--- | | Li Zhibiao | 53,593,085 | 34.53 | Domestic Natural Person | | Zhu Weili | 33,920,744 | 21.85 | Domestic Natural Person | | Li Shiyuan | 9,370,312 | 6.04 | Domestic Natural Person | | Hangzhou Xiwang Zhongchuang Industrial Investment Partnership (Limited Partnership) | 6,247,272 | 4.02 | Domestic Non-state-owned Legal Person | | Hong Kong Securities Clearing Company Limited | 5,551,768 | 3.58 | Domestic Non-state-owned Legal Person | | Wenzhou Outai Investment Enterprise (Limited Partnership) | 1,726,127 | 1.11 | Domestic Non-state-owned Legal Person | | Taikang Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Products - 019L - CT001 Shanghai | 1,343,849 | 0.87 | Domestic Non-state-owned Legal Person | | Taikang Life Insurance Co., Ltd. - Participating - Individual Participating - 019L - FH002 Shanghai | 1,244,866 | 0.80 | Domestic Non-state-owned Legal Person | | Taikang Life Insurance Co., Ltd. - Participating - Group Participating - 019L - FH001 Shanghai | 692,100 | 0.45 | Domestic Non-state-owned Legal Person | | Hong Kong Monetary Authority - Own Funds | 659,815 | 0.43 | Domestic Non-state-owned Legal Person | - Li Zhibiao and Zhu Weili are spouses, and Li Shiyuan is their daughter; the three jointly are the actual controllers of the company, directly and indirectly controlling **66.44% of Haoyue Shares**[86](index=86&type=chunk) Section VIII Preferred Shares Related Information [Preferred Shares Related Information](index=50&type=section&id=第八节%20优先股相关情况) During the reporting period, the company had no preferred shares related information Section IX Bonds Related Information [Bonds Related Information](index=51&type=section&id=第九节%20债券相关情况) During the reporting period, the company had no corporate bonds, non-financial enterprise debt financing instruments, or convertible corporate bonds Section X Financial Report [Audit Report](index=52&type=section&id=审计报告) This semi-annual report has not been audited - This semi-annual report has not been audited[2](index=2&type=chunk) [Financial Statements](index=52&type=section&id=财务报表) This section presents the company's 2024 semi-annual consolidated and parent company financial statements, including balance sheets, income statements, cash flow statements, and statements of changes in owners' equity, providing a comprehensive overview of its financial position, operating results, and cash flow - Consolidated balance sheet shows that as of June 30, 2024, the company's total assets were **4,503,507,010.88 yuan**, and total equity attributable to parent company owners was **3,281,852,138.60 yuan**[91](index=91&type=chunk) - Consolidated income statement shows that from January to June 2024, operating revenue was **1,313,081,079.32 yuan**, and net profit attributable to parent company owners was **194,022,001.88 yuan**[97](index=97&type=chunk) - Consolidated cash flow statement shows that from January to June 2024, net cash flow from operating activities was **115,002,587.69 yuan**, net cash flow from investing activities was **-737,281,599.26 yuan**, and net cash flow from financing activities was **-157,905,271.81 yuan**[103](index=103&type=chunk) [Company Basic Information](index=76&type=section&id=公司基本情况) The company, formerly Hangzhou Haoyue Industrial Co., Ltd., was restructured into a joint-stock company in 2017 and listed on the Shanghai Stock Exchange in 2020. It primarily operates in the personal hygiene products industry, with products covering infant and adult hygiene items - The company, formerly Hangzhou Haoyue Industrial Co., Ltd., was restructured into a joint-stock company in **2017** and listed on the Shanghai Stock Exchange on **September 10, 2020**[120](index=120&type=chunk) - Company's registered capital is **155.2269 million yuan**, with a total share capital of **155.2269 million shares**[120](index=120&type=chunk) - Company's main business is the R&D, production, and sales of hygiene products (feminine hygiene products; diapers and other excretion hygiene products), and composite cores, primarily including infant hygiene products, adult hygiene products, and other products[120](index=120&type=chunk) [Basis of Financial Statement Preparation](index=76&type=section&id=财务报表的编制基础) The company's financial statements are prepared on a going concern basis, and there are no matters or circumstances that raise significant doubts about its ability to continue as a going concern for 12 months from the end of the reporting period - Company's financial statements are prepared on a going concern basis[121](index=121&type=chunk) - The company has no matters or circumstances that raise significant doubts about its ability to continue as a going concern for 12 months from the end of the reporting period[122](index=122&type=chunk) [Significant Accounting Policies and Accounting Estimates](index=76&type=section&id=重要会计政策及会计估计) This section details the company's specific accounting policies and estimates across various areas, including enterprise accounting standards, financial instruments, revenue recognition, government grants, and leases - Company's financial statements comply with enterprise accounting standards, accurately and completely reflecting its financial position[123](index=123&type=chunk) - Company's accounting year runs from January 1 to December 31 of the Gregorian calendar; its operating cycle for business operations is short, using 12 months as the liquidity classification standard for assets and liabilities[124](index=124&type=chunk)[125](index=125&type=chunk) - The company and its domestic subsidiaries use RMB as their functional currency, while overseas subsidiaries use the currency of their primary economic environment as their functional currency[126](index=126&type=chunk) - Financial assets are classified at initial recognition into those measured at amortized cost, at fair value through other comprehensive income, and at fair value through profit or loss[135](index=135&type=chunk) - Revenue recognition principle is to recognize revenue when the customer obtains control of the related goods or services, and to measure revenue based on the transaction price allocated to each distinct performance obligation[170](index=170&type=chunk) - Government grants are recognized when conditions are met; asset-related government grants reduce the carrying amount of related assets or are recognized as deferred income, while income-related government grants are recognized in other income or reduce related costs and expenses[172](index=172&type=chunk)[173](index=173&type=chunk) - Company applies simplified treatment for short-term leases and leases of low-value assets, recognizing lease payments on a straight-line basis over the lease term into the cost of related assets or current profit or loss[175](index=175&type=chunk) [Taxation](index=101&type=section&id=税项) This section details the company's and its subsidiaries' main tax types, rates, and preferential tax policies, including VAT and corporate income tax incentives for high-tech and small low-profit enterprises, and additional VAT deductions for advanced manufacturing Major Tax Types and Rates | Tax Type | Tax Basis | Tax Rate | | :--- | :--- | :--- | | Value-Added Tax | Sales of goods and taxable services income | 13% (export tax refund 13%, 5%) | | Urban Maintenance and Construction Tax | Actual amount of turnover tax paid | 7%, 5% | | Corporate Income Tax | Taxable income | 15%, 20%, 25% | | Property Tax | Original value of property or rental income | 1.2%, 12% | | Education Surcharge | Actual amount of turnover tax paid | 3% | - The company and its subsidiary Jiangsu Haoyue Industrial Co., Ltd. are recognized as high-tech enterprises, and their corporate income tax for **2024** is levied at a reduced rate of **15%**[183](index=183&type=chunk) - Subsidiaries Jiangsu Jiahua Import and Export Co., Ltd., Hangzhou Chengxuan Technology Co., Ltd., Jiangsu Daoqi Pet Products Co., Ltd., and Hangzhou Haoyue New Material Co., Ltd. enjoy corporate income tax preferential policies for small low-profit enterprises, with an actual tax rate of **5%**[183](index=183&type=chunk) - The company and its subsidiary Jiangsu Haoyue Industrial Co., Ltd., as general VAT taxpayers in advanced manufacturing high-tech enterprises, enjoy a **5% additional VAT deduction policy**[184](index=184&type=chunk) [Notes to Consolidated Financial Statement Items](index=103&type=section&id=合并财务报表项目注释) This section details the period-end and beginning-of-period balances and current changes for all consolidated financial statement items, including assets, liabilities, equity, and profit/loss accounts, with explanations for significant variations Monetary Funds (Unit: Yuan) | Item | Period-end Balance | Beginning-of-period Balance | | :--- | :--- | :--- | | Cash on hand | 16,930.55 | 44,419.15 | | Bank deposits | 307,187,248.60 | 2,286,762,186.93 | | Other monetary funds | 1,205,819,363.51 | 9,142,579.89 | | Total | 1,513,023,542.66 | 2,295,949,185.97 | | Including: Total funds deposited overseas | 12,733,336.06 | 19,402,789.78 | Accounts Receivable (Unit: Yuan) | Aging | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Within 1 year | 157,086,673.48 | 72,928,852.47 | | 1 to 2 years | 627,347.42 | 938,976.18 | | Over 3 years | 11,761.29 | 11,688.51 | | Total | 157,725,782.19 | 73,879,517.16 | Inventory Classification (Unit: Yuan) | Item | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Raw materials | 166,110,367.95 | 154,288,133.13 | | Work in progress | 7,355,465.64 | 6,546,382.09 | | Finished goods | 117,527,595.05 | 116,498,500.46 | | Total | 290,993,428.64 | 277,333,015.68 | Carrying Amount of Fixed Assets (Unit: Yuan) | Item | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Buildings and structures | 685,112,383.21 | 526,541,971.49 | | Machinery and equipment | 830,537,902.56 | 863,950,198.84 | | Transportation equipment | 11,452,646.92 | 8,681,798.71 | | Other equipment | 16,366,157.16 | 18,010,978.14 | | Total | 1,543,469,089.85 | 1,417,184,947.18 | Operating Revenue and Operating Cost (Unit: Yuan) | Item | Current Period Revenue | Current Period Cost | Prior Period Revenue | Prior Period Cost | | :--- | :--- | :--- | :--- | :--- | | Main business | 1,282,379,121.80 | 923,013,714.54 | 1,328,175,621.09 | 1,001,473,657.95 | | Other business | 30,701,957.52 | 8,752,832.48 | 28,893,102.95 | 6,268,598.87 | | Total | 1,313,081,079.32 | 931,766,547.02 | 1,357,068,724.04 | 1,007,742,256.82 | Sales Expenses (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Employee compensation | 10,318,828.50 | 10,214,967.80 | | Online store promotion fees | 56,725,392.21 | 16,519,505.56 | | Advertising and publicity fees | 6,523,493.19 | 20,399,923.21 | | Consignment service fees | 10,184,129.35 | 2,818,025.21 | | Lease expenses | 4,756,043.28 | 5,402,699.90 | | Other | 5,833,844.97 | 4,116,864.17 | | Total | 94,341,731.50 | 59,471,985.85 | R&D Expenses (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Direct materials and molds | 28,500,373.29 | 29,193,982.23 | | Employee compensation | 13,333,954.45 | 12,945,409.87 | | Depreciation and amortization | 3,332,963.48 | 3,411,747.61 | | Other | 3,150,524.07 | 3,076,405.86 | | Total | 48,317,815.29 | 48,627,545.57 | Financial Expenses (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Interest expense | 7,386,207.55 | 4,832,026.29 | | Interest income | -27,901,131.51 | -32,928,034.64 | | Handling fees and other | 747,531.40 | 643,831.94 | | Exchange gains/losses | -2,194,482.23 | -1,408,961.35 | | Total | -21,961,874.79 | -28,861,137.76 | Investment Income (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Large-denomination certificate of deposit income | 1,891,862.50 | - | | Total | 1,891,862.50 | - | Income Tax Expense (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Current income tax expense | 30,485,780.89 | 37,059,243.53 | | Deferred income tax expense | -2,256,619.70 | -535,461.15 | | Total | 28,229,161.19 | 36,523,782.38 | [R&D Expenses](index=159&type=section&id=研发支出) During the reporting period, the company's total R&D expenses amounted to 48.32 million yuan, primarily comprising direct materials, employee compensation, and depreciation, all expensed R&D Expenses by Nature of Expense (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Direct materials and molds | 28,500,373.29 | 29,193,982.23 | | Employee compensation | 13,333,954.45 | 12,945,409.87 | | Depreciation and amortization | 3,332,963.48 | 3,411,747.61 | | Other | 3,150,524.07 | 3,076,405.86 | | Total | 48,317,815.29 | 48,627,545.57 | | Including: Expensed R&D expenses | 48,317,815.29 | 48,627,545.57 | | Capitalized R&D expenses | - | - | [Changes in Consolidation Scope](index=159&type=section&id=合并范围的变更) During the reporting period, the company experienced no significant changes in its consolidation scope, such as business combinations or disposal of subsidiaries leading to loss of control [Interests in Other Entities](index=162&type=section&id=在其他主体中的权益) The company owns multiple wholly-owned subsidiaries engaged in manufacturing and commerce across various locations, all acquired through establishment or business combinations under common control Composition of the Enterprise Group | Subsidiary Name | Main Operating Location | Registered Capital | Business Nature | Shareholding (Direct) | Acquisition Method | | :--- | :--- | :--- | :--- | :--- | :--- | | Jiangsu Haoyue Industrial Co., Ltd. | Suqian | 220 million yuan | Manufacturing | 100% | Business combination under common control | | Jiangsu Jiahua Import and Export Co., Ltd. | Suqian | 5.18 million yuan | Commercial | 100% | Business combination under common control | | Hangzhou Yibeijia Nursing Products Co., Ltd. | Hangzhou | 10 million yuan | Manufacturing | 100% | Establishment | | Hangzhou Chengxuan Technology Co., Ltd. | Hangzhou | 2 million yuan | Commercial | 100% | Establishment | | HAOYUE(THAILAND)CO.,LTD | Rayong, Thailand | 45 million USD | Manufacturing | 100% | Establishment | | Jiangsu Daoqi Pet Products Co., Ltd. | Suqian | 10 million yuan | Manufacturing | 100% | Establishment | | Haoyue Nursing (Hubei) Co., Ltd. | Xiaogan | 300 million yuan | Manufacturing | 100% | Establishment | | Hangzhou Haoyue New Material Co., Ltd. | Hangzhou | 30 million yuan | Manufacturing | 100% | Establishment | | Haoyue Nursing Products (Hefei) Co., Ltd. | Hefei | 300 million yuan | Manufacturing | 100% | Establishment | [Government Grants](index=163&type=section&id=政府补助) During the reporting period, the company recognized 8.81 million yuan in asset- and income-related government grants in current profit or loss, with deferred income totaling 141.62 million yuan at period-end Liability Items Involving Government Grants (Unit: Yuan) | Financial Statement Item | Beginning-of-period Balance | New Grants in Current Period | Transferred to Other Income in Current Period | Period-end Balance | Related to Asset/Income | | :--- | :--- | :--- | :--- | :--- | :--- | | Deferred income | 139,236,020.97 | 8,622,500.00 | 6,234,237.62 | 141,624,283.35 | Asset-related | Government Grants Recognized in Current Profit or Loss (Unit: Yuan) | Type | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Asset-related | 6,234,237.62 | 6,027,273.13 | | Income-related | 2,571,440.18 | 7,893,465.00 | | Total | 8,805,677.80 | 13,920,738.13 | [Risks Related to Financial Instruments](index=164&type=section&id=与金融工具相关的风险) The company manages credit, liquidity, and market risks (including interest rate and foreign exchange risks) through credit assessment, diversified financing, and foreign currency trading to balance risk and return - Company's risk management objective is to balance risk and return, minimize negative impact of risks on operating performance, and maximize shareholder interests[294](index=294&type=chunk) - Credit risk primarily arises from monetary funds and receivables; the company controls risk by depositing funds in financial institutions with high credit ratings and regularly assessing customer credit[294](index=294&type=chunk)[295](index=295&type=chunk) - Liquidity risk is managed by comprehensively utilizing various financing methods such as bill settlement and bank borrowings, and adopting an appropriate combination of long-term and short-term financing[295](index=295&type=chunk) - Market risk primarily includes interest rate risk and foreign exchange risk; the company manages these by determining the proportion of fixed-rate and floating-rate financial instruments and buying/selling foreign currencies when necessary[297](index=297&type=chunk)[298](index=298&type=chunk) Financial Liabilities Classified by Remaining Maturity (Period-end, Unit: Yuan) | Item | Carrying Amount | Within 1 Year | 1-3 Years | Over 3 Years | | :--- | :--- | :--- | :--- | :--- | | Short-term borrowings | 335,182,901.12 | 320,182,901.12 | - | - | | Notes payable | 268,786,020.39 | 268,786,020.39 | - | - | | Accounts payable | 333,623,755.33 | 333,623,755.33 | - | - | | Other payables | 25,422,068.24 | 25,422,068.24 | - | - | | Non-current liabilities due within one year | 9,174,485.88 | 9,174,485.88 | - | - | | Lease liabilities | 2,969,895.40 | - | 2,969,895.40 | - | | Subtotal | 975,159,126.36 | 957,189,230.96 | 2,969,895.40 | - | [Disclosure of Fair Value](index=168&type=section&id=公允价值的披露) This section discloses the period-end fair value of assets and liabilities measured at fair value, with accounts receivable financing totaling 41.94 million yuan, and notes that the company did not engage in hedging or disclose Level 3 fair value measurement details Fair Value of Assets and Liabilities Measured at Fair Value at Period-end (Unit: Yuan) | Item | Level 1 Fair Value Measurement | Level 2 Fair Value Measurement | Level 3 Fair Value Measurement | Total | | :--- | :--- | :--- | :--- | :--- | | Accounts receivable financing | - | 41,942,871.61 | - | 41,942,871.61 | | Total assets continuously measured at fair value | - | 41,942,871.61 | - | 41,942,871.61 | - Company did not engage in hedging activities for risk management[299](index=299&type=chunk) Financial Assets Derecognized Due to Transfer (Unit: Yuan) | Item | Method of Financial Asset Transfer | Amount of Derecognized Financial Assets | Gains or Losses Related to Derecognition | | :--- | :--- | :--- | :--- | | Accounts receivable factoring | Buyout transfer | 356,950,876.65 | 2,805,112.79 | | Bank acceptance bills | Endorsement | 230,828.84 | - | | Total | / | 357,181,705.49 | 2,805,112.79 | [Related Parties and Related Party Transactions](index=170&type=section&id=关联方及关联交易) The company's actual controllers, Li Zhibiao, Zhu Weili, and their daughter Li Shiyuan, collectively control 66.44% of the company's shares directly and indirectly; no significant related-party transactions occurred during the reporting period, except for key management personnel compensation - Company's actual controllers Li Zhibiao, Zhu Weili, and Li Shiyuan directly and indirectly collectively control **66.44% of Haoyue Shares**[304](index=304&type=chunk) Key Management Personnel Compensation (Unit: 10,000 Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Key management personnel compensation | 311.67 | 307.96 | [Share-based Payment](index=174&type=section&id=股份支付) During the reporting period, the company implemented an equity-settled share-based payment plan, recognizing 1.59 million yuan in expenses recorded in capital reserves, estimated based on unlockable employee numbers and company performance - As of June 30, 2024, the cumulative amount of equity-settled share-based payments recognized in capital reserves was **14,280,282.11 yuan**[307](index=307&type=chunk) - Total expenses recognized for equity-settled share-based payments in the current period were **1,586,698.02 yuan**, granted to management personnel[307](index=307&type=chunk)[308](index=308&type=chunk) [Commitments and Contingencies](index=175&type=section&id=承诺及或有事项) During the reporting period, the company had no significant commitments or contingencies requiring disclosure [Events After the Balance Sheet Date](index=175&type=section&id=资产负债表日后事项) After the balance sheet date, the company plans to distribute profits or dividends of 131.52 million yuan, which has been reviewed and approved for declaration and distribution Profit Distribution (Unit: Yuan) | Item | Amount | | :--- | :--- | | Proposed profit or dividend distribution | 131,515,890.45 | | Profit or dividend declared and approved for distribution | 131,515,890.45 | [Other Significant Matters](index=175&type=section&id=其他重要事项) During the reporting period, the company had no prior period accounting error corrections, significant debt restructuring, asset swaps, or annuity plans, and as its main business of absorbent hygiene products is managed as a whole, no segment information disclosure is required - Company's main business is the production and sale of absorbent hygiene products, which are managed and evaluated as a whole, thus no segment information disclosure is required[310](index=310&type=chunk) Section XIX Notes to Parent Company Financial Statement Items [Accounts Receivable](index=177&type=section&id=应收账款) The parent company's accounts receivable balance at period-end was 118.06 million yuan, predominantly within one year, with an impairment provision of 5.91 million yuan primarily based on aging groups Parent Company Accounts Receivable by Aging (Unit: Yuan) | Aging | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Within 1 year | 118,052,177.02 | 55,152,732.78 | | 1 to 2 years | 3,387.13 | 2,026,961.17 | | Over 3 years | 6,671.97 | 6,630.68 | | Total | 118,062,236.12 | 57,186,324.63 | Parent Company Accounts Receivable Impairment Provision (Unit: Yuan) | Category | Period-end Impairment Provision Amount | Provision Rate (%) | | :--- | :--- | :--- | | Impairment provision based on portfolio | 5,909,958.25 | 5.01 | | Total | 5,909,958.25 | 5.01 | Parent Company Top Five Accounts Receivable and Contract Assets by Debtor at Period-end (Unit: Yuan) | Unit Name | Period-end Accounts Receivable | Proportion of Total Period-end Accounts Receivable and Contract Assets (%) | Period-end Impairment Provision | | :--- | :--- | :--- | :--- | | Customer 1 | 69,789,200.96 | 59.11 | 3,489,460.05 | | Customer 2 | 12,723,648.72 | 10.78 | 636,182.44 | | Customer 3 | 6,508,354.58 | 5.51 | 325,417.73 | | Customer 4 | 5,238,084.61 | 4.44 | 261,904.24 | | Customer 5 | 3,341,703.14 | 2.83 | 167,085.16 | | Total | 97,600,992.01 | 82.67 | 4,880,049.62 | [Other Receivables](index=179&type=section&id=其他应收款) The parent company's other receivables balance at period-end was 13.11 million yuan, mainly comprising deposits and temporary advances, with an impairment provision of 1.96 million yuan based on credit risk stages Parent Company Other Receivables by Aging (Unit: Yuan) | Aging | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Within 1 year | 13,002,847.30 | 4,022,459.54 | | 1 to 2 years | 62,027.37 | 868,702.93 | | 2 to 3 years | 1,400,296.32 | 1,021,000.22 | | Over 3 years | 603,664.00 | 603,664.00 | | Total | 15,068,834.99 | 6,515,826.69 | Parent Company Other Receivables by Nature of Payment (Unit: Yuan) | Nature of Payment | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Deposits and guarantees | 14,399,460.94 | 4,019,973.15 | | Export tax refund receivable | 120,800.00 | - | | Temporary advances receivable | - | 2,474,053.54 | | Petty cash | - | 21,800.00 | | Total | 15,068,834.99 | 6,515,826.69 | Parent Company Other Receivables Impairment Provision (Unit: Yuan) | Category | Beginning-of-period Balance | Increase in Current Period | Period-end Balance | | :--- | :--- | :--- | :--- | | Impairment provision based on portfolio | 1,365,325.00 | 597,501.57 | 1,962,826.57 | | Total | 1,365,325.00 | 597,501.57 | 1,962,826.57 | Parent Company Top Five Other Receivables by Debtor at Period-end (Unit: Yuan) | Unit Name | Period-end Balance | Proportion of Total Period-end Other Receivables (%) | Nature of Payment | Aging | Period-end Impairment Provision | | :--- | :--- | :--- | :--- | :--- | :--- | | Unit 1 | 10,340,000.00 | 68.62 | Deposits and guarantees | Within 1 year | 517,000.00 | | Unit 2 | 1,096,000.00 | 7.27 | Deposits and guarantees | Within 1 year | 54,800.00 | | Unit 3 | 639,721.00 | 4.25 | Deposits and guarantees | Within 1 year, Over 3 years | 584,566.85 | | Unit 4 | 300,000.00 | 1.99 | Temporary advances receivable | Within 1 year | 15,000.00 | | Unit 5 | 200,000.00 | 1.33 | Deposits and guarantees | Within 1 year | 10,000.00 | | Total | 12,575,721.00 | 83.46 | / | / | 1,181,366.85 | [Long-term Equity Investments](index=184&type=section&id=长期股权投资) The parent company's long-term equity investments totaled 992.23 million yuan at period-end, primarily in subsidiaries, with increased investments in Haoyue Nursing (Hubei) and Haoyue Nursing Products (Hefei) during the period Parent Company Long-term Equity Investments (Unit: Yuan) | Item | Period-end Carrying Amount | Beginning-of-period Carrying Amount | | :--- | :--- | :--- | | Investments in subsidiaries | 992,234,209.82 | 681,234,209.82 | | Total | 992,234,209.82 | 681,234,209.82 | Parent Company Changes in Investments in Subsidiaries (Unit: Yuan) | Investee Company | Beginning-of-period Balance | Increase in Current Period | Period-end Balance | | :--- | :--- | :--- | :--- | | Jiangsu Haoyue Industrial Co., Ltd. | 216,903,657.21 | - | 216,903,657.21 | | Haoyue Nursing (Hubei) Co., Ltd. | 200,000,000.00 | 40,000,000.00 | 240,000,000.00 | | Haoyue Nursing Products (Hefei) Co., Ltd. | - | 265,000,000.00 | 265,000,000.00 | | Total | 681,234,209.82 | 311,000,000.00 | 992,234,209.82 | [Operating Revenue and Operating Cost](index=185&type=section&id=营业收入和营业成本) The parent company's operating revenue for the reporting period was 1.10 billion yuan and operating cost was 843.07 million yuan, with main business revenue, particularly infant hygiene products, being the largest contributor Parent Company Operating Revenue and Operating Cost (Unit: Yuan) | Item | Current Period Revenue | Current Period Cost | Prior Period Revenue | Prior Period Cost | | :--- | :--- | :--- | :--- | :--- | | Main business | 1,074,060,217.55 | 830,741,801.86 | 1,227,764,241.56 | 947,395,439.60 | | Other business | 29,506,422.19 | 12,329,273.98 | 28,337,542.45 | 20,218,864.20 | | Total | 1,103,566,639.74 | 843,071,075.84 | 1,256,101,784.01 | 967,614,303.80 | Parent Company Operating Revenue and Operating Cost Breakdown (by Product Type, Unit: Yuan) | Product Type | Operating Revenue | Operating Cost | | :--- | :--- | :--- | | Infant hygiene products | 841,493,178.77 | 663,112,432.75 | | Adult hygiene products | 215,497,292.70 | 163,781,087.21 | | Other products | 46,576,168.27 | 16,177,555.88 | | Total | 1,103,566,639.74 | 843,071,075.84 | [Investment Income](index=186&type=section&id=投资收益) The parent company's investment income for the current period primarily derived from large-denomination certificate of deposit income, amounting to 1.89 million yuan Parent Company Investment Income (Unit: Yuan) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Large-denomination certificate of deposit income | 1,891,862.50 | - | | Total | 1,891,862.50 | - | Section XX Supplementary Information [Schedule of Non-recurring Gains and Losses for the Current Period](index=186&type=section&id=当期非经常性损益明细表) Total non-recurring gains and losses for the current period amounted to 2.42 million yuan, primarily from government subsidies and investment income, showing a difference in net non-recurring gains and losses compared to the first half of 2023 Details of Non-recurring Gains and Losses for the Current Period (Unit: Yuan) | Item | Amount | | :--- | :--- | | Disposal gains/losses of non-current assets | -176,232.39 | | Government subsidies recognized in current profit/loss | 2,571,440.18 | | Gains/losses from entrusted investments or asset management | 1,891,862.50 | | Reversal of impairment provisions for receivables subject to separate impairment testing | 220,000.00 | | Other non-operating income and expenses | -1,657,616.85 | | Less: Income tax impact | 426,031.37 | | Total | 2,423,422.07 | Net Non-recurring Gains and Losses Difference (Unit: Yuan) | Item | Amount Involved | | :--- | :--- | | Net non-recurring gains and losses attributable to parent company owners for H1 2023 | 16,415,840.26 | | Net non-recurring gains and losses attributable to parent company owners for H1 2023 calculated under new regulations | 11,016,503.66 | | Difference | 5,399,336.60 | [Return on Net Assets and Earnings Per Share](index=188&type=section&id=净资产收益率及每股收益) During the reporting period, the weighted average return on net assets attributable to common shareholders was 5.88%, with both basic and diluted earnings per share at 1.24 yuan/share Return on Net Assets and Earnings Per Share | Profit for the Reporting Period | Weighted Average Return on Equity (%) | Basic Earnings Per Share (Yuan) | Diluted Earnings Per Share (Yuan) | | :--- | :--- | :--- | :--- | | Net profit attributable to common shareholders of the company | 5.88 | 1.24 | 1.24 | | Net profit attributable to common shareholders of the company after deducting non-recurring gains and losses | 5.81 | 1.23 | 1.23 |

证券代码：605009 证券简称：豪悦护理 公告编号：2024-031 杭州豪悦护理用品股份有限公司 关于召开 2024 年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2024 年第二次临时股东大会 召开的日期时间：2024 年 9 月 9 日 14 点 30 分 召开地点：浙江省杭州市临平区东湖街道临平经济技术开发区红丰路 655 号 公司会议室 股东大会召开日期：2024年9月9日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2024 年 9 月 9 日 至 2024 年 9 月 9 日 采用上海证券交易所网络投票系统，通过交易系统 ...

重要内容提示： 一、利润分配预案内容 根据公司《2024 年半年度报告》（未经审计），截至 2024 年 6 月 30 日，公 司实现归属于母公司所有者的净利润为人民币 194,022,001.88 元，期末可供分 配利润为人民币 1,512,976,478.17 元。为使股东分享公司发展的经营成果，根 据公司目前的资金状况，公司董事会拟定的 2024 年半年度利润分配方案如下： 以实施权益分派股权登记日的总股本扣除公司回购专户的股份余额为基数， 拟向全体股东按每 10 股派发现金红利人民币 8.5 元(含税)，截至本公告日，公 司总股本 155,226,949 元，扣除回购证券专用账户的股份 502,372 股，以余额 154,724,577 股为基数计算合计拟派发现金红利 131,515,890.45 元（含税），占 公司 2023 年度合并报表归属于母公司所有者净利润的比例为 67.78%。本次利润 分配方案实施后,剩余未分配利润全部结转以后年度分配。 每股分配比例：每 10 股派发现金红利 8.5 元（含税）。 本次利润分配以实施权益分派股权登记日登记的总股本扣除回购账户 中已回购股份后的股份余额为基 ...